chr1-8656247-T-TCGGTCC

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBS1BS2

The NM_001042681.2(RERE):​c.45_50dupGGACCG​(p.Arg17_Asp18insAspArg) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.00874 in 1,613,208 control chromosomes in the GnomAD database, including 81 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0063 ( 4 hom., cov: 31)
Exomes 𝑓: 0.0090 ( 77 hom. )

Consequence

RERE
NM_001042681.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 6.80

Publications

0 publications found
Variant links:
Genes affected
RERE (HGNC:9965): (arginine-glutamic acid dipeptide repeats) This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RERE Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder with or without congenital anomalies
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without anomalies of the brain, eye, or heart
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_001042681.2.
BP6
Variant 1-8656247-T-TCGGTCC is Benign according to our data. Variant chr1-8656247-T-TCGGTCC is described in ClinVar as Benign. ClinVar VariationId is 377359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00628 (955/152186) while in subpopulation NFE AF = 0.00947 (644/67990). AF 95% confidence interval is 0.00887. There are 4 homozygotes in GnomAd4. There are 482 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 955 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RERENM_001042681.2 linkc.45_50dupGGACCG p.Arg17_Asp18insAspArg disruptive_inframe_insertion Exon 2 of 23 ENST00000400908.7 NP_001036146.1
RERENM_012102.4 linkc.45_50dupGGACCG p.Arg17_Asp18insAspArg disruptive_inframe_insertion Exon 3 of 24 NP_036234.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
REREENST00000400908.7 linkc.45_50dupGGACCG p.Arg17_Asp18insAspArg disruptive_inframe_insertion Exon 2 of 23 1 NM_001042681.2 ENSP00000383700.2

Frequencies

GnomAD3 genomes
AF:
0.00627
AC:
954
AN:
152068
Hom.:
4
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00133
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.0190
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00947
Gnomad OTH
AF:
0.00431
GnomAD2 exomes
AF:
0.00641
AC:
1607
AN:
250740
AF XY:
0.00664
show subpopulations
Gnomad AFR exome
AF:
0.00144
Gnomad AMR exome
AF:
0.00156
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0185
Gnomad NFE exome
AF:
0.00876
Gnomad OTH exome
AF:
0.00508
GnomAD4 exome
AF:
0.00900
AC:
13149
AN:
1461022
Hom.:
77
Cov.:
31
AF XY:
0.00895
AC XY:
6504
AN XY:
726892
show subpopulations
African (AFR)
AF:
0.00117
AC:
39
AN:
33458
American (AMR)
AF:
0.00192
AC:
86
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
30
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00306
AC:
264
AN:
86238
European-Finnish (FIN)
AF:
0.0177
AC:
943
AN:
53420
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5762
European-Non Finnish (NFE)
AF:
0.0102
AC:
11323
AN:
1111252
Other (OTH)
AF:
0.00734
AC:
443
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
659
1318
1976
2635
3294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
424
848
1272
1696
2120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00628
AC:
955
AN:
152186
Hom.:
4
Cov.:
31
AF XY:
0.00648
AC XY:
482
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.00132
AC:
55
AN:
41548
American (AMR)
AF:
0.00151
AC:
23
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00332
AC:
16
AN:
4820
European-Finnish (FIN)
AF:
0.0190
AC:
202
AN:
10616
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00947
AC:
644
AN:
67990
Other (OTH)
AF:
0.00426
AC:
9
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00764
Hom.:
0
Asia WGS
AF:
0.00144
AC:
5
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RERE: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.8
Mutation Taster
=60/40
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201665914; hg19: chr1-8716306; API